Observed changes in PSA and PGR expression in prostate and breast tumors as markers of AR and ERα signaling, respectively, reflected the natural tumor heterogeneity observed clinically for each tumor type examined (Arnedos et al., 2013). The gene discussed is ESR1; the disease is breast neoplasm.